Comparison of (68)Ga-PSMA PET/CT and (18)F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall.

Creative Commons License

Soydal Ç., Demir B., Sütçü G., Araz M., Küçük N. Ö.

Molecular imaging and radionuclide therapy, vol.32, no.2, pp.150-152, 2023 (ESCI) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 2
  • Publication Date: 2023
  • Doi Number: 10.4274/mirt.galenos.2023.47550
  • Journal Name: Molecular imaging and radionuclide therapy
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.150-152
  • Keywords: Cancer, prostate, positron emission tomography, Ga-68-PSMA, F-18-PSMA
  • Ankara University Affiliated: Yes

Abstract

Prostate cancer is one of the most prevalent cancers in the world. After radical prostatectomy, prostate-specific antigen (PSA) levels are usually used as a marker of recurrence for prostate cancer. In the case of increased PSA levels,68Ga-prostate-specific membrane antigen (PSMA) or 18 F-PSMA, a new alternative, can be performed for the detection of recurrent disease. We report a case of a 49-year-old male patient with increasing PSA levels who was previously operated 8 years ago. Although no obvious pathological uptake was detected in68Ga-PSMA positron emission tomography/computed tomography (PET/CT),18F-PSMA PET/CT revealed a lesion with pathological uptake on the urinary bladder wall.